Taiwan stocks fluctuated today (15), although financial and industrial sectors struggled to support the market, biotech stocks were favored by buyers, driving theweighted indexIt has become popular several times, but the electronics and shipping groups are weak, plusFingering periodAfter the settlement, selling pressure emerged in the last session before the end, and the broader market fell 48 points to close at 15,999 points, with a transaction value of 223.053 billion yuan. Five foreign companies sold in a row, and the three major legal persons sold a total of over 13.353 billion yuan.
Observing the changes in the capital of the three major legal persons today, foreign capital continued to withdraw 19.178 billion yuan, and the cumulative 5 trading days have sold nearly 119 billion yuan; investment trust sold more than 290 million yuan; proprietors bought more than 6.114 billion yuan. The three major legal persons sold a total of over 13.353 billion yuan.
Electronic weight stocks were mixed. TSMC fluctuated all the way down the market, and fell nearly 0.8% at the end to close at 509 yuan. Delta, Largan, Novatek, and ASE Investment Control were under heavy selling pressure, all down more than 1% However, Hon Hai, Yageo, MediaTek, UMC, Quanta and others struggled to support the market, and AUO closed up 2.4%.
The central banks of the United States, the United Kingdom, Japan, Taiwan and other central banks are regarding to announce the results of the latest interest rate decisions. Financial stocks opened lower and higher. CITIC Gold, National Paper Gold, Shanghai Commercial Bank, Antai Bank, Want Want, Xinchan, etc. rose by regarding 1-2% , Fubon Gold closed down. Shipping stocks were sluggish today. Evergreen fell 2.7%, Yang Ming and Wanhai also fell more than 1%, and Taihua Investment Control, Yumin, Xinxing, and AVIC fell simultaneously.
There has been a lot of good news in the biotechnology industry recently. Following the signing of a new drug authorization contract of 20 billion yuan between Taiwan Micros and Endo, a major international pharmaceutical company, Paul Rui once once more launched mergers and acquisitions, and plans to buy Anchengyao for 6 billion yuan, driving the overall performance of biotechnology stocks. , Bao Rui, Deying, Polaris Pharmaceutical-KY and many other gears all turned on their daily limit, and the listed biotech stocks index rose by more than 2% at the end, including Tanglian, Heyi, Taikang Biotechnology, Yida, Xingyi , Zhongyu, etc. also performed well.
In terms of high-priced stocks, the stock king Sili-KY tumbled nearly 4% to close at 2,490 yuan, while Spectra-KY, Liwang, and AES-KY fell 3-4% simultaneously. AirTAC-KY returned to the top of the list yesterday. , continued to rise 2% today, and Xin Hua, Xu Falcon, and Xiangshuo also performed on the plate.
The Asian foreign investment downgraded the rating of Nandian to “underweight”, and the ratings of Xinxing and Jingshuo were rated as “hold”, which caused selling pressure on the three ABF carrier boards today, and both Xinxing and Jingshuo plunged more than 9%. %, Nandian also fell nearly 4%; however, other PCB stocks performed well, such as Jianding, Jingpeng, Yaohua, Jingchengke, etc., rose regarding 1-3%.